Oncology

A new study suggests vitamin B2 may help cancer cells survive by protecting them from programmed cell death, and a related compound, roseoflavin, could trigger this cell death.

A clinical trial found that nine weeks of immunotherapy before surgery kept specific colorectal cancer patients cancer-free for nearly three years.